Alyssa Kortschinsky
Psychiatric/Mental Health · Warwick, RINPI 1629473590
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 360 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,554, more than ten times the $48 reported in 2023. Among psychiatric/mental health clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 360 payments — averaging $22.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$882
- Vanda Pharmaceuticals Inc.$877
- Alkermes, Inc.$831
- Axsome Therapeutics, Inc.$753
- plus $2K from 12 others
What the payments were for
- Food & beverage$8,072100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $1,431 |
| Otsuka America Pharmaceutical, Inc. | 52 | $1,112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 41 | $882 |
| Vanda Pharmaceuticals Inc. | 36 | $877 |
| Alkermes, Inc. | 28 | $831 |
| Axsome Therapeutics, Inc. | 25 | $753 |
| Lundbeck LLC | 21 | $339 |
| Tris Pharma Inc | 20 | $332 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $287 |
| Corium, LLC | 13 | $245 |
| Collegium Pharmaceutical, Inc. | 15 | $229 |
| Johnson & Johnson | 8 | $223 |
| Neurocrine Biosciences, Inc. | 6 | $161 |
| Teva Pharmaceuticals USA, Inc. | 6 | $147 |
| Neos Therapeutics, LP | 5 | $88 |
| Supernus Pharmaceuticals, Inc. | 4 | $70 |
| Bausch Health US, LLC | 3 | $57 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,084 in reported general payments places this provider in the 95th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acamprosate Calcium | 11 | $979 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 24 | $751 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Warwick
- Katie ThayerWarwick$16K
- Arielle RoundsWarwick$15K
- Deborah HorvitzWarwick$10K
- Mark GauthierWarwick$8K
- Sarah WeinreichWarwick$5K
- Cathy KennedyWarwick$4K
- Shaylah SpellmanWarwick$2K
- Brett MichelsonWarwick$1K
- Cindy PatrickWarwick$1K
- Samantha Shawn MarshBradford$639K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.